17662049_1|17662049|2326|#section_info|0:0|In addition, PECAM-1, which is expressed in endothelial cells, monocytes, neutrophils and specific T lymphocyte subsets, is directly involved in diapedesis via homophilic interactions between migrating leukocytes, particularly monocytes/neutrophils and endothelial intercellular junctions (Muller et al. 1993).|#main_body|GO:0050904|diapedesis|#go_definition|TAS|GOA|Pecam1(29583)|#gene_synonym
0.74	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_234|17662049|37174|Discussion|0:0|PECAM-1 is required for transendothelial migration of leukocytes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_2|17662049|93|abstract|0:0|Interactions between leukocytes and vascular endothelial cells are mediated by a complex set of membrane adhesion molecules which transduce bi-directional signals in both cell types.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_8|17662049|1526|abstract|0:0|Leukocyte extravasation into tissues involves a complex set of adhesion molecules at the surface of leukocytes and vascular endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_142|17662049|26237|Discussion|0:0|ICAM-1 signaling in endothelial cells thus appears to participate in the trans-endothelial migration of leucocytes to inflammation sites.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_178|17662049|31043|Discussion|0:0|We and others provided compelling evidence that ICAM-1-induced signaling and subsequent actin cytoskeleton remodeling was directly involved in the process of trans-endothelial migration of activated leukocytes (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_191|17662049|32057|Discussion|0:0|Moreover, recent studies have demonstrated that leukocyte adhesion promotes the remodeling of the apical endothelial plasma membrane into projections that surround adherent leukocytes (Carman and Springer 2004; Shaw et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_250|17662049|39167|Discussion|0:0|ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_171|17662049|29084|Discussion|0:0|This is to our knowledge the first evidence that PECAM-1 engagement can negatively regulate the signaling pathways coupled to another leukocyte adhesion molecule in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_210|17662049|34447|Discussion|0:0|Endothelial cells proactively form microvilli-like membrane projections upon intercellular adhesion molecule 1 engagement of leukocyte LFA-1|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_214|17662049|34845|Discussion|0:0|Neisseria meningitidis infection of human endothelial cells interferes with leukocyte transmigration by preventing the formation of endothelial docking structures|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_172|17662049|29084|Discussion|0:0|This observation strongly suggests that leukocyte adhesion and transmigration trigger in endothelial cells a complex set of interconnected positive and negative signalings which cooperate for controlling the dynamics of endothelial response.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_232|17662049|36942|Discussion|0:0|Platelet endothelial cell adhesion molecule-1 is a major SH-PTP2 binding protein in vascular endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_12|17662049|1526|abstract|0:0|Nevertheless, in pathological situations, such as multiple sclerosis, viral or bacterial infections, numerous activated lymphocytes, monocytes or neutrophils can cross the BBB (Carson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_195|17662049|32057|Discussion|0:0|These structures, referred to as endothelial docking structures or transmigratory cups, are essential to promote firm adhesion and extravasation of leukocytes through paracellular as well as transcellular routes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_199|17662049|32057|Discussion|0:0|In addition, because PECAM-1 is not present in endothelial docking structures, it will be necessary to identify the cellular compartments where the signalling cross-talk reported here may take place.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_225|17662049|36264|Discussion|0:0|Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_233|17662049|37053|Discussion|0:0|Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_243|17662049|38267|Discussion|0:0|Locomotion of monocytes on endothelium is a critical step during extravasation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_9|17662049|1526|abstract|0:0|Tethering or rolling of leukocytes is followed by their firm adhesion to endothelium, their locomotion (Schenkel et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_141|17662049|26237|Discussion|0:0|2003), ICAM-1 behaves as a signal transducer, activating multiple signaling pathways in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_2|17662049|2326|#section_info|0:0|aradoxically, however, gene deficiency for PECAM-1 was recently found to increase the number of activated leukocytes crossing the BBB, suggesting that PECAM-1 might play a more complex role in leukocyte extravasation than previously recognized (Graesser et al. 2002).|#main_body|GO:0045123|cellular extravasation|#go_definition|TAS|GOA|Pecam1(29583)|#gene_synonym
0.72	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_7|17662049|93|abstract|0:0|Our findings reveal a novel activity for PECAM-1 which, by counteracting ICAM-1-induced activation, could directly contribute to limit activation and maintain integrity of brain vascular endothelium.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_198|17662049|32057|Discussion|0:0|Future studies will aim at evaluating the functional relevance of these findings, by evaluating the role of the PECAM-1 cytoplasmic domain and associated signaling in regulation of leukocyte transmigration across brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_56|17662049|9764|Materials and methods|0:0|The anti-MHC II antibody used here as an isotype-matched control antibody was previously shown not only to bind to IFN-gamma-activated RBE4 cells, but also to trigger signaling pathways in RBE4 cells distinct from those activated by ICAM-1 cross-linking (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_178|17662049|31043|Discussion|0:0|We and others provided compelling evidence that ICAM-1-induced signaling and subsequent actin cytoskeleton remodeling was directly involved in the process of trans-endothelial migration of activated leukocytes (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_191|17662049|32057|Discussion|0:0|Moreover, recent studies have demonstrated that leukocyte adhesion promotes the remodeling of the apical endothelial plasma membrane into projections that surround adherent leukocytes (Carman and Springer 2004; Shaw et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_234|17662049|37174|Discussion|0:0|PECAM-1 is required for transendothelial migration of leukocytes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_12|17662049|1526|abstract|0:0|Nevertheless, in pathological situations, such as multiple sclerosis, viral or bacterial infections, numerous activated lymphocytes, monocytes or neutrophils can cross the BBB (Carson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_151|17662049|26237|Discussion|0:0|In addition, it has been suggested that SHP-2 might associate with tyrosine phosphorylated ICAM-1, even though ICAM-1 does not contain a bona fide SHP-2 binding site, such as a consensus immunoreceptor tyrosine-based inhibitory motif (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_171|17662049|29084|Discussion|0:0|This is to our knowledge the first evidence that PECAM-1 engagement can negatively regulate the signaling pathways coupled to another leukocyte adhesion molecule in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_199|17662049|32057|Discussion|0:0|In addition, because PECAM-1 is not present in endothelial docking structures, it will be necessary to identify the cellular compartments where the signalling cross-talk reported here may take place.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_3|17662049|2326|#section_info|0:0|In addition, PECAM-1, which is expressed in endothelial cells, monocytes, neutrophils and specific T lymphocyte subsets, is directly involved in diapedesis via homophilic interactions between migrating leukocytes, particularly monocytes/neutrophils and endothelial intercellular junctions |#main_body|GO:0050904|diapedesis|#go_definition|TAS|GOA|Pecam1(29583)|#gene_synonym
0.76	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_234|17662049|37174|Discussion|0:0|PECAM-1 is required for transendothelial migration of leukocytes|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_2|17662049|93|abstract|0:0|Interactions between leukocytes and vascular endothelial cells are mediated by a complex set of membrane adhesion molecules which transduce bi-directional signals in both cell types.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_8|17662049|1526|abstract|0:0|Leukocyte extravasation into tissues involves a complex set of adhesion molecules at the surface of leukocytes and vascular endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_142|17662049|26237|Discussion|0:0|ICAM-1 signaling in endothelial cells thus appears to participate in the trans-endothelial migration of leucocytes to inflammation sites.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_250|17662049|39167|Discussion|0:0|ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_210|17662049|34447|Discussion|0:0|Endothelial cells proactively form microvilli-like membrane projections upon intercellular adhesion molecule 1 engagement of leukocyte LFA-1|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_233|17662049|37053|Discussion|0:0|Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_243|17662049|38267|Discussion|0:0|Locomotion of monocytes on endothelium is a critical step during extravasation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_171|17662049|29084|Discussion|0:0|This is to our knowledge the first evidence that PECAM-1 engagement can negatively regulate the signaling pathways coupled to another leukocyte adhesion molecule in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_172|17662049|29084|Discussion|0:0|This observation strongly suggests that leukocyte adhesion and transmigration trigger in endothelial cells a complex set of interconnected positive and negative signalings which cooperate for controlling the dynamics of endothelial response.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_195|17662049|32057|Discussion|0:0|These structures, referred to as endothelial docking structures or transmigratory cups, are essential to promote firm adhesion and extravasation of leukocytes through paracellular as well as transcellular routes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_214|17662049|34845|Discussion|0:0|Neisseria meningitidis infection of human endothelial cells interferes with leukocyte transmigration by preventing the formation of endothelial docking structures|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_232|17662049|36942|Discussion|0:0|Platelet endothelial cell adhesion molecule-1 is a major SH-PTP2 binding protein in vascular endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_178|17662049|31043|Discussion|0:0|We and others provided compelling evidence that ICAM-1-induced signaling and subsequent actin cytoskeleton remodeling was directly involved in the process of trans-endothelial migration of activated leukocytes (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_205|17662049|33887|Discussion|0:0|Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_246|17662049|38602|Discussion|0:0|Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_199|17662049|32057|Discussion|0:0|In addition, because PECAM-1 is not present in endothelial docking structures, it will be necessary to identify the cellular compartments where the signalling cross-talk reported here may take place.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_219|17662049|35515|Discussion|0:0|ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_225|17662049|36264|Discussion|0:0|Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_4|17662049|3003|#section_info|0:0|Using brain endothelial cell lines, we previously provided evidence that ICAM-1 antibody cross-linking led to an increase in intracellular Ca2+ concentration, protein kinase C activation, phosphorylation of cortactin and other actin-binding proteins by the Src tyrosine kinase, activation of RhoA GTPase, and subsequent rearrangements of the actin cytoskeleton (Durieu-Trautmann et al. 1994; Greenwood et al. 2002; Carman and Springer 2004; Shaw et al. 2004; Yang et al. 2005; Millan et al. 2006).|#main_body|GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation|#go_definition|TAS|GOA|Icam1(25464)|#gene_synonym
0.71	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_140|17662049|26237|Discussion|0:0|2002; Carman et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_182|17662049|31043|Discussion|0:0|2005; Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_192|17662049|32057|Discussion|0:0|2004; Barreiro et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_191|17662049|32057|Discussion|0:0|Moreover, recent studies have demonstrated that leukocyte adhesion promotes the remodeling of the apical endothelial plasma membrane into projections that surround adherent leukocytes (Carman and Springer 2004; Shaw et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_57|17662049|9764|Materials and methods|0:0|1994; Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_166|17662049|29084|Discussion|0:0|2001; Patil et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_180|17662049|31043|Discussion|0:0|2002; Carman and Springer 2004; Shaw et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_201|17662049|32057|Discussion|0:0|2006; Viegas et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_58|17662049|9764|Materials and methods|0:0|1999; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_179|17662049|31043|Discussion|0:0|1994; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_27|17662049|6116|Materials and methods|0:0|1994; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_85|17662049|13033|Results|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_146|17662049|26237|Discussion|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_149|17662049|26237|Discussion|0:0|1996; Celli et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_168|17662049|29084|Discussion|0:0|2002; Gratzinger et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_185|17662049|31043|Discussion|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_48|17662049|7995|Materials and methods|0:0|1998; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_159|17662049|28313|Discussion|0:0|2002; Wang et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_165|17662049|29084|Discussion|0:0|1997; Henshall et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_167|17662049|29084|Discussion|0:0|2001; Cicmil et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_181|17662049|31043|Discussion|0:0|2004; Yang et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_193|17662049|32057|Discussion|0:0|2005; Doulet et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_84|17662049|13033|Results|0:0|1998; Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_120|17662049|21915|Results|0:0|2000; Gopalakrishnan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_145|17662049|26237|Discussion|0:0|1998; Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_160|17662049|28313|Discussion|0:0|2003; Kontaridis et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_49|17662049|7995|Materials and methods|0:0|2000; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_5|17662049|3003|#section_info|0:0|Using brain endothelial cell lines, we previously provided evidence that ICAM-1 antibody cross-linking led to an increase in intracellular Ca2+ concentration, protein kinase C activation, phosphorylation of cortactin and other actin-binding proteins by the Src tyrosine kinase, activation of RhoA GTPase, and subsequent rearrangements of the actin cytoskeleton (Durieu-Trautmann et al. 1994; Greenwood et al. 2002; Carman and Springer 2004; Shaw et al. 2004; Yang et al. 2005; Millan et al. 2006).|#main_body|GO:0007204|elevation of cytosolic calcium ion concentration|#go_definition|TAS|GOA|Icam1(25464)|#gene_synonym
0.71	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_140|17662049|26237|Discussion|0:0|2002; Carman et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_182|17662049|31043|Discussion|0:0|2005; Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_192|17662049|32057|Discussion|0:0|2004; Barreiro et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_191|17662049|32057|Discussion|0:0|Moreover, recent studies have demonstrated that leukocyte adhesion promotes the remodeling of the apical endothelial plasma membrane into projections that surround adherent leukocytes (Carman and Springer 2004; Shaw et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_57|17662049|9764|Materials and methods|0:0|1994; Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_166|17662049|29084|Discussion|0:0|2001; Patil et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_180|17662049|31043|Discussion|0:0|2002; Carman and Springer 2004; Shaw et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_201|17662049|32057|Discussion|0:0|2006; Viegas et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_58|17662049|9764|Materials and methods|0:0|1999; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_179|17662049|31043|Discussion|0:0|1994; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_27|17662049|6116|Materials and methods|0:0|1994; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_85|17662049|13033|Results|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_146|17662049|26237|Discussion|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_149|17662049|26237|Discussion|0:0|1996; Celli et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_168|17662049|29084|Discussion|0:0|2002; Gratzinger et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_185|17662049|31043|Discussion|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_48|17662049|7995|Materials and methods|0:0|1998; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_159|17662049|28313|Discussion|0:0|2002; Wang et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_165|17662049|29084|Discussion|0:0|1997; Henshall et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_167|17662049|29084|Discussion|0:0|2001; Cicmil et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_181|17662049|31043|Discussion|0:0|2004; Yang et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_193|17662049|32057|Discussion|0:0|2005; Doulet et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_84|17662049|13033|Results|0:0|1998; Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_120|17662049|21915|Results|0:0|2000; Gopalakrishnan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_145|17662049|26237|Discussion|0:0|1998; Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_160|17662049|28313|Discussion|0:0|2003; Kontaridis et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_49|17662049|7995|Materials and methods|0:0|2000; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_6|17662049|3003|#section_info|0:0|Using brain endothelial cell lines, we previously provided evidence that ICAM-1 antibody cross-linking led to an increase in intracellular Ca2+ concentration, protein kinase C activation, phosphorylation of cortactin and other actin-binding proteins by the Src tyrosine kinase, activation of RhoA GTPase, and subsequent rearrangements of the actin cytoskeleton (Durieu-Trautmann et al. 1994; Greenwood et al. 2002; Carman and Springer 2004; Shaw et al. 2004; Yang et al. 2005; Millan et al. 2006).|#main_body|GO:0032862|activation of Rho GTPase activity|#go_definition|TAS|GOA|Icam1(25464)|#gene_synonym
0.71	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_140|17662049|26237|Discussion|0:0|2002; Carman et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_182|17662049|31043|Discussion|0:0|2005; Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_192|17662049|32057|Discussion|0:0|2004; Barreiro et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_191|17662049|32057|Discussion|0:0|Moreover, recent studies have demonstrated that leukocyte adhesion promotes the remodeling of the apical endothelial plasma membrane into projections that surround adherent leukocytes (Carman and Springer 2004; Shaw et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_57|17662049|9764|Materials and methods|0:0|1994; Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_166|17662049|29084|Discussion|0:0|2001; Patil et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_180|17662049|31043|Discussion|0:0|2002; Carman and Springer 2004; Shaw et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_201|17662049|32057|Discussion|0:0|2006; Viegas et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_58|17662049|9764|Materials and methods|0:0|1999; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_179|17662049|31043|Discussion|0:0|1994; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_27|17662049|6116|Materials and methods|0:0|1994; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_85|17662049|13033|Results|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_146|17662049|26237|Discussion|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_149|17662049|26237|Discussion|0:0|1996; Celli et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_168|17662049|29084|Discussion|0:0|2002; Gratzinger et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_185|17662049|31043|Discussion|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_48|17662049|7995|Materials and methods|0:0|1998; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_159|17662049|28313|Discussion|0:0|2002; Wang et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_165|17662049|29084|Discussion|0:0|1997; Henshall et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_167|17662049|29084|Discussion|0:0|2001; Cicmil et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_181|17662049|31043|Discussion|0:0|2004; Yang et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_193|17662049|32057|Discussion|0:0|2005; Doulet et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_84|17662049|13033|Results|0:0|1998; Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_120|17662049|21915|Results|0:0|2000; Gopalakrishnan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_145|17662049|26237|Discussion|0:0|1998; Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_160|17662049|28313|Discussion|0:0|2003; Kontaridis et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_49|17662049|7995|Materials and methods|0:0|2000; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_7|17662049|3003|#section_info|0:0|Using brain endothelial cell lines, we previously provided evidence that ICAM-1 antibody cross-linking led to an increase in intracellular Ca2+ concentration, protein kinase C activation, phosphorylation of cortactin and other actin-binding proteins by the Src tyrosine kinase, activation of RhoA GTPase, and subsequent rearrangements of the actin cytoskeleton (Durieu-Trautmann et al. 1994; Greenwood et al. 2002; Carman and Springer 2004; Shaw et al. 2004; Yang et al. 2005; Millan et al. 2006).|#main_body|GO:0031532|actin cytoskeleton reorganization|#go_definition|TAS|GOA|Icam1(25464)|#gene_synonym
0.71	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_140|17662049|26237|Discussion|0:0|2002; Carman et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_182|17662049|31043|Discussion|0:0|2005; Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_192|17662049|32057|Discussion|0:0|2004; Barreiro et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_191|17662049|32057|Discussion|0:0|Moreover, recent studies have demonstrated that leukocyte adhesion promotes the remodeling of the apical endothelial plasma membrane into projections that surround adherent leukocytes (Carman and Springer 2004; Shaw et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_57|17662049|9764|Materials and methods|0:0|1994; Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_166|17662049|29084|Discussion|0:0|2001; Patil et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_180|17662049|31043|Discussion|0:0|2002; Carman and Springer 2004; Shaw et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_201|17662049|32057|Discussion|0:0|2006; Viegas et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_58|17662049|9764|Materials and methods|0:0|1999; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_179|17662049|31043|Discussion|0:0|1994; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_27|17662049|6116|Materials and methods|0:0|1994; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_85|17662049|13033|Results|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_146|17662049|26237|Discussion|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_149|17662049|26237|Discussion|0:0|1996; Celli et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_168|17662049|29084|Discussion|0:0|2002; Gratzinger et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_185|17662049|31043|Discussion|0:0|1999; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_48|17662049|7995|Materials and methods|0:0|1998; Etienne-Manneville et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_159|17662049|28313|Discussion|0:0|2002; Wang et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_165|17662049|29084|Discussion|0:0|1997; Henshall et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_167|17662049|29084|Discussion|0:0|2001; Cicmil et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_181|17662049|31043|Discussion|0:0|2004; Yang et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_193|17662049|32057|Discussion|0:0|2005; Doulet et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_84|17662049|13033|Results|0:0|1998; Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_120|17662049|21915|Results|0:0|2000; Gopalakrishnan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_145|17662049|26237|Discussion|0:0|1998; Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_160|17662049|28313|Discussion|0:0|2003; Kontaridis et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_49|17662049|7995|Materials and methods|0:0|2000; Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_8|17662049|3003|#section_info|0:0|Besides, PECAM-1 has been abundantly documented as a signaling receptor which can transduce either inhibitory or stimulatory signals with cell-specificity, such as inhibition of the antigen receptor signaling in T lymphocytes or stimulation of the intracellular calcium level in endothelial cells (Newman et al. 2001; Newman and Newman 2003).|#main_body|GO:0038023|signaling receptor activity|#go_definition|TAS|GOA|Pecam1(29583)|#gene_synonym
0.69	17662049_174|17662049|29084|Discussion|0:0|This hypothesis is in line with the interpretation proposed for PECAM-1 inhibition of growth factor or antigen receptor signaling pathways (Newman et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_2|17662049|93|abstract|0:0|Interactions between leukocytes and vascular endothelial cells are mediated by a complex set of membrane adhesion molecules which transduce bi-directional signals in both cell types.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_56|17662049|9764|Materials and methods|0:0|The anti-MHC II antibody used here as an isotype-matched control antibody was previously shown not only to bind to IFN-gamma-activated RBE4 cells, but also to trigger signaling pathways in RBE4 cells distinct from those activated by ICAM-1 cross-linking (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_157|17662049|28313|Discussion|0:0|SHP-2 is known as an upstream mediator of multiple signaling pathways, but contrasting data in various cell systems present it either as a negative or a positive regulator of RhoA and other pathways (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_9|17662049|3003|#section_info|0:0|Besides, PECAM-1 has been abundantly documented as a signaling receptor which can transduce either inhibitory or stimulatory signals with cell-specificity, such as inhibition of the antigen receptor signaling in T lymphocytes or stimulation of the intracellular calcium level in endothelial cells (Newman et al. 2001; Newman and Newman 2003).|#main_body|GO:0007204|elevation of cytosolic calcium ion concentration|#go_definition|TAS|GOA|Pecam1(29583)|#gene_synonym
0.69	17662049_174|17662049|29084|Discussion|0:0|This hypothesis is in line with the interpretation proposed for PECAM-1 inhibition of growth factor or antigen receptor signaling pathways (Newman et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_2|17662049|93|abstract|0:0|Interactions between leukocytes and vascular endothelial cells are mediated by a complex set of membrane adhesion molecules which transduce bi-directional signals in both cell types.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_56|17662049|9764|Materials and methods|0:0|The anti-MHC II antibody used here as an isotype-matched control antibody was previously shown not only to bind to IFN-gamma-activated RBE4 cells, but also to trigger signaling pathways in RBE4 cells distinct from those activated by ICAM-1 cross-linking (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_157|17662049|28313|Discussion|0:0|SHP-2 is known as an upstream mediator of multiple signaling pathways, but contrasting data in various cell systems present it either as a negative or a positive regulator of RhoA and other pathways (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_10|17662049|3003|#section_info|0:0|Besides, PECAM-1 has been abundantly documented as a signaling receptor which can transduce either inhibitory or stimulatory signals with cell-specificity, such as inhibition of the antigen receptor signaling in T lymphocytes or stimulation of the intracellular calcium level in endothelial cells (Newman et al. 2001; Newman and Newman 2003).|#main_body|GO:0050858|negative regulation of antigen receptor-mediated signaling pathway|#go_definition|TAS|GOA|Pecam1(29583)|#gene_synonym
0.69	17662049_174|17662049|29084|Discussion|0:0|This hypothesis is in line with the interpretation proposed for PECAM-1 inhibition of growth factor or antigen receptor signaling pathways (Newman et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_2|17662049|93|abstract|0:0|Interactions between leukocytes and vascular endothelial cells are mediated by a complex set of membrane adhesion molecules which transduce bi-directional signals in both cell types.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_56|17662049|9764|Materials and methods|0:0|The anti-MHC II antibody used here as an isotype-matched control antibody was previously shown not only to bind to IFN-gamma-activated RBE4 cells, but also to trigger signaling pathways in RBE4 cells distinct from those activated by ICAM-1 cross-linking (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_157|17662049|28313|Discussion|0:0|SHP-2 is known as an upstream mediator of multiple signaling pathways, but contrasting data in various cell systems present it either as a negative or a positive regulator of RhoA and other pathways (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_11|17662049|3003|#section_info|0:0|Using brain endothelial cell lines, we previously provided evidence that ICAM-1 antibody cross-linking led to an increase in intracellular Ca2+ concentration, protein kinase C activation, phosphorylation of cortactin and other actin-binding proteins by the Src tyrosine kinase, activation of RhoA GTPase, and subsequent rearrangements of the actin cytoskeleton|#main_body|GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation|#go_definition|TAS|GOA|Icam1(25464)|#gene_synonym
0.86	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.81	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_219|17662049|35515|Discussion|0:0|ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_249|17662049|39056|Discussion|0:0|Activation of Src tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_218|17662049|35353|Discussion|0:0|MHC class II engagement in brain endothelial cells induces protein kinase A-dependent IL-6 secretion and phosphorylation of cAMP response element-binding protein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_124|17662049|23562|Results|0:0|Following cortactin immunoprecipitation, immunoblotting with anti-phosphotyrosine antibodies (clone 4 G10) or anti-cortactin antibodies detected tyrosine-phosphorylated cortactin or total amount of cortactin, respectively.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_184|17662049|31043|Discussion|0:0|Pharmacological inhibition of ICAM-1 coupled signalling pathways, using Rho kinase inhibitors or calcium chelators, largely prevented the migration of activated lymphocytes across RBE4 cells (Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_240|17662049|37890|Discussion|0:0|The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_217|17662049|35255|Discussion|0:0|ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_12|17662049|3003|#section_info|0:0|Using brain endothelial cell lines, we previously provided evidence that ICAM-1 antibody cross-linking led to an increase in intracellular Ca2+ concentration, protein kinase C activation, phosphorylation of cortactin and other actin-binding proteins by the Src tyrosine kinase, activation of RhoA GTPase, and subsequent rearrangements of the actin cytoskeleton|#main_body|GO:0007204|elevation of cytosolic calcium ion concentration|#go_definition|TAS|GOA|Icam1(25464)|#gene_synonym
0.86	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.81	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_219|17662049|35515|Discussion|0:0|ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_249|17662049|39056|Discussion|0:0|Activation of Src tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_218|17662049|35353|Discussion|0:0|MHC class II engagement in brain endothelial cells induces protein kinase A-dependent IL-6 secretion and phosphorylation of cAMP response element-binding protein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_124|17662049|23562|Results|0:0|Following cortactin immunoprecipitation, immunoblotting with anti-phosphotyrosine antibodies (clone 4 G10) or anti-cortactin antibodies detected tyrosine-phosphorylated cortactin or total amount of cortactin, respectively.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_184|17662049|31043|Discussion|0:0|Pharmacological inhibition of ICAM-1 coupled signalling pathways, using Rho kinase inhibitors or calcium chelators, largely prevented the migration of activated lymphocytes across RBE4 cells (Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_240|17662049|37890|Discussion|0:0|The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_217|17662049|35255|Discussion|0:0|ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_13|17662049|3003|#section_info|0:0|Using brain endothelial cell lines, we previously provided evidence that ICAM-1 antibody cross-linking led to an increase in intracellular Ca2+ concentration, protein kinase C activation, phosphorylation of cortactin and other actin-binding proteins by the Src tyrosine kinase, activation of RhoA GTPase, and subsequent rearrangements of the actin cytoskeleton|#main_body|GO:0032862|activation of Rho GTPase activity|#go_definition|TAS|GOA|Icam1(25464)|#gene_synonym
0.86	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.81	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_219|17662049|35515|Discussion|0:0|ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_249|17662049|39056|Discussion|0:0|Activation of Src tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_218|17662049|35353|Discussion|0:0|MHC class II engagement in brain endothelial cells induces protein kinase A-dependent IL-6 secretion and phosphorylation of cAMP response element-binding protein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_124|17662049|23562|Results|0:0|Following cortactin immunoprecipitation, immunoblotting with anti-phosphotyrosine antibodies (clone 4 G10) or anti-cortactin antibodies detected tyrosine-phosphorylated cortactin or total amount of cortactin, respectively.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_184|17662049|31043|Discussion|0:0|Pharmacological inhibition of ICAM-1 coupled signalling pathways, using Rho kinase inhibitors or calcium chelators, largely prevented the migration of activated lymphocytes across RBE4 cells (Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_240|17662049|37890|Discussion|0:0|The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_217|17662049|35255|Discussion|0:0|ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_14|17662049|3003|#section_info|0:0|Using brain endothelial cell lines, we previously provided evidence that ICAM-1 antibody cross-linking led to an increase in intracellular Ca2+ concentration, protein kinase C activation, phosphorylation of cortactin and other actin-binding proteins by the Src tyrosine kinase, activation of RhoA GTPase, and subsequent rearrangements of the actin cytoskeleton|#main_body|GO:0031532|actin cytoskeleton reorganization|#go_definition|TAS|GOA|Icam1(25464)|#gene_synonym
0.86	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.81	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_219|17662049|35515|Discussion|0:0|ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_249|17662049|39056|Discussion|0:0|Activation of Src tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_218|17662049|35353|Discussion|0:0|MHC class II engagement in brain endothelial cells induces protein kinase A-dependent IL-6 secretion and phosphorylation of cAMP response element-binding protein|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_124|17662049|23562|Results|0:0|Following cortactin immunoprecipitation, immunoblotting with anti-phosphotyrosine antibodies (clone 4 G10) or anti-cortactin antibodies detected tyrosine-phosphorylated cortactin or total amount of cortactin, respectively.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_184|17662049|31043|Discussion|0:0|Pharmacological inhibition of ICAM-1 coupled signalling pathways, using Rho kinase inhibitors or calcium chelators, largely prevented the migration of activated lymphocytes across RBE4 cells (Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_240|17662049|37890|Discussion|0:0|The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_217|17662049|35255|Discussion|0:0|ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_15|17662049|3003|#section_info|0:0|Besides, PECAM-1 has been abundantly documented as a signaling receptor which can transduce either inhibitory or stimulatory signals with cell-specificity, such as inhibition of the antigen receptor signaling in T lymphocytes or stimulation of the intracellular calcium level in endothelial cells|#main_body|GO:0038023|signaling receptor activity|#go_definition|TAS|GOA|Pecam1(29583)|#gene_synonym
0.68	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_2|17662049|93|abstract|0:0|Interactions between leukocytes and vascular endothelial cells are mediated by a complex set of membrane adhesion molecules which transduce bi-directional signals in both cell types.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_199|17662049|32057|Discussion|0:0|In addition, because PECAM-1 is not present in endothelial docking structures, it will be necessary to identify the cellular compartments where the signalling cross-talk reported here may take place.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_236|17662049|37357|Discussion|0:0|Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck)|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_16|17662049|3003|#section_info|0:0|Besides, PECAM-1 has been abundantly documented as a signaling receptor which can transduce either inhibitory or stimulatory signals with cell-specificity, such as inhibition of the antigen receptor signaling in T lymphocytes or stimulation of the intracellular calcium level in endothelial cells|#main_body|GO:0007204|elevation of cytosolic calcium ion concentration|#go_definition|TAS|GOA|Pecam1(29583)|#gene_synonym
0.68	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_2|17662049|93|abstract|0:0|Interactions between leukocytes and vascular endothelial cells are mediated by a complex set of membrane adhesion molecules which transduce bi-directional signals in both cell types.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_199|17662049|32057|Discussion|0:0|In addition, because PECAM-1 is not present in endothelial docking structures, it will be necessary to identify the cellular compartments where the signalling cross-talk reported here may take place.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_236|17662049|37357|Discussion|0:0|Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck)|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_17|17662049|3003|#section_info|0:0|Besides, PECAM-1 has been abundantly documented as a signaling receptor which can transduce either inhibitory or stimulatory signals with cell-specificity, such as inhibition of the antigen receptor signaling in T lymphocytes or stimulation of the intracellular calcium level in endothelial cells|#main_body|GO:0050858|negative regulation of antigen receptor-mediated signaling pathway|#go_definition|TAS|GOA|Pecam1(29583)|#gene_synonym
0.68	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_2|17662049|93|abstract|0:0|Interactions between leukocytes and vascular endothelial cells are mediated by a complex set of membrane adhesion molecules which transduce bi-directional signals in both cell types.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_199|17662049|32057|Discussion|0:0|In addition, because PECAM-1 is not present in endothelial docking structures, it will be necessary to identify the cellular compartments where the signalling cross-talk reported here may take place.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_236|17662049|37357|Discussion|0:0|Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck)|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_18|17662049|4113|#section_info|0:0|We report in the present study that PECAM-1 engagement unexpectedly down-regulated ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|GO:0050732|negative regulation of peptidyl-tyrosine phosphorylation|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.83	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.79	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.75	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_19|17662049|4113|#section_info|0:0|We report in the present study that PECAM-1 engagement unexpectedly down-regulated ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|GO:0030837|negative regulation of actin filament polymerization|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.83	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.79	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.75	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_20|17662049|4113|#section_info|0:0|We report in the present study that PECAM-1 engagement unexpectedly down-regulated ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.83	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.79	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.75	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_21|17662049|4113|#section_info|0:0|We report in the present study that PECAM-1 engagement unexpectedly down-regulated ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|GO:0030838|positive regulation of actin filament polymerization|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.83	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.79	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.75	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_22|17662049|13033|#section_info|0:0|We previously documented that ICAM-1 cross-linking at the surface of the rat brain endothelial RBE4 cells lead to actin cytoskeleton rearrangements through activation of RhoA GTPase|#main_body|GO:0031532|actin cytoskeleton reorganization|#go_definition|TAS|GOA|Icam1(25464)|#gene_synonym
0.8	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_219|17662049|35515|Discussion|0:0|ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_217|17662049|35255|Discussion|0:0|ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_205|17662049|33887|Discussion|0:0|Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_184|17662049|31043|Discussion|0:0|Pharmacological inhibition of ICAM-1 coupled signalling pathways, using Rho kinase inhibitors or calcium chelators, largely prevented the migration of activated lymphocytes across RBE4 cells (Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_249|17662049|39056|Discussion|0:0|Activation of Src tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_54|17662049|9298|Materials and methods|0:0|Experimental procedure for sequential cross-linking of ICAM-1 and/or PECAM-1 at the surface of cultured endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_23|17662049|13033|#section_info|0:0|We previously documented that ICAM-1 cross-linking at the surface of the rat brain endothelial RBE4 cells lead to actin cytoskeleton rearrangements through activation of RhoA GTPase|#main_body|GO:0031532|actin cytoskeleton reorganization|#go_definition|TAS|GOA|Rhoa(117273)|#gene_synonym
0.8	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_219|17662049|35515|Discussion|0:0|ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_217|17662049|35255|Discussion|0:0|ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_205|17662049|33887|Discussion|0:0|Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_184|17662049|31043|Discussion|0:0|Pharmacological inhibition of ICAM-1 coupled signalling pathways, using Rho kinase inhibitors or calcium chelators, largely prevented the migration of activated lymphocytes across RBE4 cells (Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_249|17662049|39056|Discussion|0:0|Activation of Src tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_54|17662049|9298|Materials and methods|0:0|Experimental procedure for sequential cross-linking of ICAM-1 and/or PECAM-1 at the surface of cultured endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_24|17662049|13033|#section_info|0:0|ICAM-1 cross-linking induced the formation of numerous actin stress fibers across RBE4 cells (Fig. 1b);|#main_body|GO:0030838|positive regulation of actin filament polymerization|#go_definition|IDA|GOA|Icam1(25464)|#gene_synonym
0.77	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_25|17662049|13033|#section_info|0:0|Unexpectedly, we did not observe any stress fiber formation following sequential antibody cross-linking of ICAM-1 and PECAM-1 (Fig. 1d).|#main_body|GO:0005884|actin filament|#go_definition|IDA|GOA|Pecam1(29583)|#gene_synonym
0.78	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_45|17662049|7956|Materials and methods|0:0|Ab cross-linking of ICAM-1 and PECAM-1|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_54|17662049|9298|Materials and methods|0:0|Experimental procedure for sequential cross-linking of ICAM-1 and/or PECAM-1 at the surface of cultured endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_90|17662049|13033|Results|0:0|As control, cross-linking of ICAM-1 followed by incubation with buffer alone or with the isotype-matched anti-MHC-II antibody (Fig. 1e) or anti-transferrin antibody (not shown) or again with the same anti-ICAM-1 antibody (not shown) imilar results were observed using the human microvascular endothelial cell line HBMEC of peripheral origin (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_26|17662049|13033|#section_info|0:0|did not affect the ICAM-1-induced formation of stress fibers. |#main_body|GO:0030838|positive regulation of actin filament polymerization|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
##EndOfRet##
17662049_27|17662049|13033|#section_info|0:0|These results indicate that PECAM-1 engagement drastically blocked the ICAM-1-induced cortical actin polymerization in RBE4 cells and human endothelial cells.|#main_body|GO:0030838|positive regulation of actin filament polymerization|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.74	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_171|17662049|29084|Discussion|0:0|This is to our knowledge the first evidence that PECAM-1 engagement can negatively regulate the signaling pathways coupled to another leukocyte adhesion molecule in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_219|17662049|35515|Discussion|0:0|ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_28|17662049|13033|#section_info|0:0|These results indicate that PECAM-1 engagement drastically blocked the ICAM-1-induced cortical actin polymerization in RBE4 cells and human endothelial cells.|#main_body|GO:0030837|negative regulation of actin filament polymerization|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.74	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_171|17662049|29084|Discussion|0:0|This is to our knowledge the first evidence that PECAM-1 engagement can negatively regulate the signaling pathways coupled to another leukocyte adhesion molecule in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_219|17662049|35515|Discussion|0:0|ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_29|17662049|14442|#section_info|0:0|PECAM-1 cross-linking reverses ICAM-1-induced actin cytoskeleton rearrangements. Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|GO:0030837|negative regulation of actin filament polymerization|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.83	17662049_107|17662049|20880|Results|0:0|Panel (a) Cross-linking of ICAM-1 or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.8	17662049_110|17662049|20880|Results|0:0|Panel (b) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated mock-transfected HBMECs or stably expressing WT-SHP-2 or Dn-SHP-2 as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.8	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_54|17662049|9298|Materials and methods|0:0|Experimental procedure for sequential cross-linking of ICAM-1 and/or PECAM-1 at the surface of cultured endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_45|17662049|7956|Materials and methods|0:0|Ab cross-linking of ICAM-1 and PECAM-1|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_46|17662049|7995|Materials and methods|0:0|Confluent endothelial cells were pre-incubated with serum- and growth factor-free culture medium containing 100 U/mL IFN-gamma for 48 h, before Ab cross-linking of ICAM-1 and/or PECAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_30|17662049|14442|#section_info|0:0|PECAM-1 cross-linking reverses ICAM-1-induced actin cytoskeleton rearrangements. Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|GO:0030838|positive regulation of actin filament polymerization|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.83	17662049_107|17662049|20880|Results|0:0|Panel (a) Cross-linking of ICAM-1 or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.8	17662049_110|17662049|20880|Results|0:0|Panel (b) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated mock-transfected HBMECs or stably expressing WT-SHP-2 or Dn-SHP-2 as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.8	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_54|17662049|9298|Materials and methods|0:0|Experimental procedure for sequential cross-linking of ICAM-1 and/or PECAM-1 at the surface of cultured endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_45|17662049|7956|Materials and methods|0:0|Ab cross-linking of ICAM-1 and PECAM-1|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_46|17662049|7995|Materials and methods|0:0|Confluent endothelial cells were pre-incubated with serum- and growth factor-free culture medium containing 100 U/mL IFN-gamma for 48 h, before Ab cross-linking of ICAM-1 and/or PECAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_31|17662049|14442|#section_info|0:0|PECAM-1 cross-linking reverses ICAM-1-induced actin cytoskeleton rearrangements.|#fig_caption|GO:0030837|negative regulation of actin filament polymerization|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.92	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_32|17662049|14442|#section_info|0:0|PECAM-1 cross-linking reverses ICAM-1-induced actin cytoskeleton rearrangements.|#fig_caption|GO:0030838|positive regulation of actin filament polymerization|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.92	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_33|17662049|15397|#section_info|0:0|Following ICAM-1 cross-linking or control treatment, cell extracts containing equal amounts of RhoA protein (as confirmed by western blotting: not shown) were incubated with the the Rhotekin-GST fusion protein: a large amount of retained (i.e. activated) RhoA was detected following ICAM-1 cross-linking (Fig. 1f, lane b), compared to basal conditions (Fig. 1f, lane a), confirming our previous finding that ICAM-1 cross-linking induces a strong activation of RhoA in RBE4 cells.|#main_body|GO:0032321|positive regulation of Rho GTPase activity|#go_definition|IDA|GOA|Icam1(25464)|#gene_synonym
0.73	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_90|17662049|13033|Results|0:0|As control, cross-linking of ICAM-1 followed by incubation with buffer alone or with the isotype-matched anti-MHC-II antibody (Fig. 1e) or anti-transferrin antibody (not shown) or again with the same anti-ICAM-1 antibody (not shown) imilar results were observed using the human microvascular endothelial cell line HBMEC of peripheral origin (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_56|17662049|9764|Materials and methods|0:0|The anti-MHC II antibody used here as an isotype-matched control antibody was previously shown not only to bind to IFN-gamma-activated RBE4 cells, but also to trigger signaling pathways in RBE4 cells distinct from those activated by ICAM-1 cross-linking (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_110|17662049|20880|Results|0:0|Panel (b) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated mock-transfected HBMECs or stably expressing WT-SHP-2 or Dn-SHP-2 as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_126|17662049|23562|Results|0:0|Panels (b-e) IFN-gamma-treated RBE4 cells were treated or not with calpeptin (150 mug/mL for 30 min) prior to ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_88|17662049|13033|Results|0:0|Here, we confirmed that, whereas polymerized actin was mainly cortical in basal condition (incubation with Rabbit anti-Mouse antibodies) (Fig. 1a), this response was maintained over the entire incubation period (50 min).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_107|17662049|20880|Results|0:0|Panel (a) Cross-linking of ICAM-1 or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_60|17662049|10094|Materials and methods|0:0|In order to inhibit SHP-2 phosphatase, endothelial cells (RBE-4 or HBMECs) were treated with 150 mug/mL of calpeptin (Calbiochem, La Jolla, CA, USA) for 30 min prior to ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_78|17662049|11987|Materials and methods|0:0|The beads were washed three times with lysis buffer, and then bound proteins were analyzed by SDS-PAGE and western blotting as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_34|17662049|15397|#section_info|0:0|Following ICAM-1 cross-linking or control treatment, cell extracts containing equal amounts of RhoA protein (as confirmed by western blotting: not shown) were incubated with the the Rhotekin-GST fusion protein: a large amount of retained (i.e. activated) RhoA was detected following ICAM-1 cross-linking (Fig. 1f, lane b), compared to basal conditions (Fig. 1f, lane a), confirming our previous finding that ICAM-1 cross-linking induces a strong activation of RhoA in RBE4 cells.|#main_body|GO:0005515|protein binding|#go_definition|NONE|GOA|Rhoa(117273)|#gene_synonym
0.73	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_90|17662049|13033|Results|0:0|As control, cross-linking of ICAM-1 followed by incubation with buffer alone or with the isotype-matched anti-MHC-II antibody (Fig. 1e) or anti-transferrin antibody (not shown) or again with the same anti-ICAM-1 antibody (not shown) imilar results were observed using the human microvascular endothelial cell line HBMEC of peripheral origin (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_56|17662049|9764|Materials and methods|0:0|The anti-MHC II antibody used here as an isotype-matched control antibody was previously shown not only to bind to IFN-gamma-activated RBE4 cells, but also to trigger signaling pathways in RBE4 cells distinct from those activated by ICAM-1 cross-linking (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_110|17662049|20880|Results|0:0|Panel (b) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated mock-transfected HBMECs or stably expressing WT-SHP-2 or Dn-SHP-2 as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_126|17662049|23562|Results|0:0|Panels (b-e) IFN-gamma-treated RBE4 cells were treated or not with calpeptin (150 mug/mL for 30 min) prior to ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_88|17662049|13033|Results|0:0|Here, we confirmed that, whereas polymerized actin was mainly cortical in basal condition (incubation with Rabbit anti-Mouse antibodies) (Fig. 1a), this response was maintained over the entire incubation period (50 min).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_107|17662049|20880|Results|0:0|Panel (a) Cross-linking of ICAM-1 or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_60|17662049|10094|Materials and methods|0:0|In order to inhibit SHP-2 phosphatase, endothelial cells (RBE-4 or HBMECs) were treated with 150 mug/mL of calpeptin (Calbiochem, La Jolla, CA, USA) for 30 min prior to ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_78|17662049|11987|Materials and methods|0:0|The beads were washed three times with lysis buffer, and then bound proteins were analyzed by SDS-PAGE and western blotting as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_35|17662049|15397|#section_info|0:0|PECAM-1 cross-linking per se did not activate RhoA (Fig. 1f, lane c), but completely inhibited ICAM-1-induced RhoA activation (Fig. 1f, lane d). As a control, the irrelevant isotype-matched anti-MHC-II antibody had no effect on ICAM-1 response (Fig. 1f, lane e). These results provide further evidence that PECAM-1 cross-linking affects the ICAM-1-induced cortical actin polymerization by interfering with RhoA activation.|#main_body|GO:0034259|negative regulation of Rho GTPase activity|#go_definition|IDA|GOA|Icam1(25464)|#gene_synonym
0.73	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_109|17662049|20880|Results|0:0|Lane a: basal condition; lane b: PECAM-1 cross-linking; lane c: basal condition; lane d: ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_36|17662049|15397|#section_info|0:0|PECAM-1 cross-linking per se did not activate RhoA (Fig. 1f, lane c), but completely inhibited ICAM-1-induced RhoA activation (Fig. 1f, lane d). As a control, the irrelevant isotype-matched anti-MHC-II antibody had no effect on ICAM-1 response (Fig. 1f, lane e). These results provide further evidence that PECAM-1 cross-linking affects the ICAM-1-induced cortical actin polymerization by interfering with RhoA activation.|#main_body|GO:0032321|positive regulation of Rho GTPase activity|#go_definition|IDA|GOA|Icam1(25464)|#gene_synonym
0.73	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_109|17662049|20880|Results|0:0|Lane a: basal condition; lane b: PECAM-1 cross-linking; lane c: basal condition; lane d: ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_37|17662049|15397|#section_info|0:0|PECAM-1 cross-linking per se did not activate RhoA (Fig. 1f, lane c), but completely inhibited ICAM-1-induced RhoA activation (Fig. 1f, lane d). As a control, the irrelevant isotype-matched anti-MHC-II antibody had no effect on ICAM-1 response (Fig. 1f, lane e). These results provide further evidence that PECAM-1 cross-linking affects the ICAM-1-induced cortical actin polymerization by interfering with RhoA activation.|#main_body|GO:0030836|positive regulation of actin filament depolymerization|#go_definition|IDA|GOA|Icam1(25464)|#gene_synonym
0.73	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_109|17662049|20880|Results|0:0|Lane a: basal condition; lane b: PECAM-1 cross-linking; lane c: basal condition; lane d: ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_38|17662049|15397|#section_info|0:0|Following ICAM-1 cross-linking or control treatment, cell extracts containing equal amounts of RhoA protein (as confirmed by western blotting: not shown) were incubated with the the Rhotekin-GST fusion protein: a large amount of retained (i.e. activated) RhoA was detected following ICAM-1 cross-linking (Fig. 1f, lane b), compared to basal conditions (Fig. 1f, lane a), confirming our previous finding that ICAM-1 cross-linking induces a strong activation of RhoA in RBE4 cells.|#main_body|GO:0003924|GTPase activity|#go_definition|IDA|GOA|Icam1(25464)|#gene_synonym
0.73	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_90|17662049|13033|Results|0:0|As control, cross-linking of ICAM-1 followed by incubation with buffer alone or with the isotype-matched anti-MHC-II antibody (Fig. 1e) or anti-transferrin antibody (not shown) or again with the same anti-ICAM-1 antibody (not shown) imilar results were observed using the human microvascular endothelial cell line HBMEC of peripheral origin (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_56|17662049|9764|Materials and methods|0:0|The anti-MHC II antibody used here as an isotype-matched control antibody was previously shown not only to bind to IFN-gamma-activated RBE4 cells, but also to trigger signaling pathways in RBE4 cells distinct from those activated by ICAM-1 cross-linking (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_110|17662049|20880|Results|0:0|Panel (b) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated mock-transfected HBMECs or stably expressing WT-SHP-2 or Dn-SHP-2 as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_126|17662049|23562|Results|0:0|Panels (b-e) IFN-gamma-treated RBE4 cells were treated or not with calpeptin (150 mug/mL for 30 min) prior to ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_88|17662049|13033|Results|0:0|Here, we confirmed that, whereas polymerized actin was mainly cortical in basal condition (incubation with Rabbit anti-Mouse antibodies) (Fig. 1a), this response was maintained over the entire incubation period (50 min).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_107|17662049|20880|Results|0:0|Panel (a) Cross-linking of ICAM-1 or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_60|17662049|10094|Materials and methods|0:0|In order to inhibit SHP-2 phosphatase, endothelial cells (RBE-4 or HBMECs) were treated with 150 mug/mL of calpeptin (Calbiochem, La Jolla, CA, USA) for 30 min prior to ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_78|17662049|11987|Materials and methods|0:0|The beads were washed three times with lysis buffer, and then bound proteins were analyzed by SDS-PAGE and western blotting as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_39|17662049|15397|#section_info|0:0|Following ICAM-1 cross-linking or control treatment, cell extracts containing equal amounts of RhoA protein (as confirmed by western blotting: not shown) were incubated with the the Rhotekin-GST fusion protein: a large amount of retained (i.e. activated) RhoA was detected following ICAM-1 cross-linking (Fig. 1f, lane b), compared to basal conditions (Fig. 1f, lane a), confirming our previous finding that ICAM-1 cross-linking induces a strong activation of RhoA in RBE4 cells.|#main_body|GO:0005515|protein binding|#go_definition|NONE|GOA|Rhoa(117273)|#gene_synonym
0.73	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_90|17662049|13033|Results|0:0|As control, cross-linking of ICAM-1 followed by incubation with buffer alone or with the isotype-matched anti-MHC-II antibody (Fig. 1e) or anti-transferrin antibody (not shown) or again with the same anti-ICAM-1 antibody (not shown) imilar results were observed using the human microvascular endothelial cell line HBMEC of peripheral origin (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_56|17662049|9764|Materials and methods|0:0|The anti-MHC II antibody used here as an isotype-matched control antibody was previously shown not only to bind to IFN-gamma-activated RBE4 cells, but also to trigger signaling pathways in RBE4 cells distinct from those activated by ICAM-1 cross-linking (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_110|17662049|20880|Results|0:0|Panel (b) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated mock-transfected HBMECs or stably expressing WT-SHP-2 or Dn-SHP-2 as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_126|17662049|23562|Results|0:0|Panels (b-e) IFN-gamma-treated RBE4 cells were treated or not with calpeptin (150 mug/mL for 30 min) prior to ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_88|17662049|13033|Results|0:0|Here, we confirmed that, whereas polymerized actin was mainly cortical in basal condition (incubation with Rabbit anti-Mouse antibodies) (Fig. 1a), this response was maintained over the entire incubation period (50 min).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_107|17662049|20880|Results|0:0|Panel (a) Cross-linking of ICAM-1 or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_60|17662049|10094|Materials and methods|0:0|In order to inhibit SHP-2 phosphatase, endothelial cells (RBE-4 or HBMECs) were treated with 150 mug/mL of calpeptin (Calbiochem, La Jolla, CA, USA) for 30 min prior to ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_78|17662049|11987|Materials and methods|0:0|The beads were washed three times with lysis buffer, and then bound proteins were analyzed by SDS-PAGE and western blotting as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_40|17662049|15397|#section_info|0:0|PECAM-1 cross-linking per se did not activate RhoA (Fig. 1f, lane c), but completely inhibited ICAM-1-induced RhoA activation (Fig. 1f, lane d). As a control, the irrelevant isotype-matched anti-MHC-II antibody had no effect on ICAM-1 response (Fig. 1f, lane e). These results provide further evidence that PECAM-1 cross-linking affects the ICAM-1-induced cortical actin polymerization by interfering with RhoA activation.|#main_body|GO:0034259|negative regulation of Rho GTPase activity|#go_definition|IDA|GOA|Pecam1(29583)|#gene_synonym
0.73	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_109|17662049|20880|Results|0:0|Lane a: basal condition; lane b: PECAM-1 cross-linking; lane c: basal condition; lane d: ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_41|17662049|15397|#section_info|0:0|PECAM-1 cross-linking per se did not activate RhoA (Fig. 1f, lane c), but completely inhibited ICAM-1-induced RhoA activation (Fig. 1f, lane d). As a control, the irrelevant isotype-matched anti-MHC-II antibody had no effect on ICAM-1 response (Fig. 1f, lane e). These results provide further evidence that PECAM-1 cross-linking affects the ICAM-1-induced cortical actin polymerization by interfering with RhoA activation.|#main_body|GO:0030838|positive regulation of actin filament polymerization|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.73	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_109|17662049|20880|Results|0:0|Lane a: basal condition; lane b: PECAM-1 cross-linking; lane c: basal condition; lane d: ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_42|17662049|16894|#section_info|0:0|Together with actin polymerization, we previously documented that ICAM-1 cross-linking strongly stimulated the tyrosine kinase Src activity and tyrosine phosphorylation of several actin-binding proteins, including cortactin. This response was maintained over extended periods of time (for at least 60 min)|#main_body|GO:0001934|positive regulation of protein phosphorylation|#go_definition|TAS|GOA|Icam1(25464)|#gene_synonym
0.77	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_88|17662049|13033|Results|0:0|Here, we confirmed that, whereas polymerized actin was mainly cortical in basal condition (incubation with Rabbit anti-Mouse antibodies) (Fig. 1a), this response was maintained over the entire incubation period (50 min).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_151|17662049|26237|Discussion|0:0|In addition, it has been suggested that SHP-2 might associate with tyrosine phosphorylated ICAM-1, even though ICAM-1 does not contain a bona fide SHP-2 binding site, such as a consensus immunoreceptor tyrosine-based inhibitory motif (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_196|17662049|32057|Discussion|0:0|Formation of these docking structures results from the dynamic redistribution of several adhesion molecules including ICAM-1 and actin polymerization.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_178|17662049|31043|Discussion|0:0|We and others provided compelling evidence that ICAM-1-induced signaling and subsequent actin cytoskeleton remodeling was directly involved in the process of trans-endothelial migration of activated leukocytes (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_240|17662049|37890|Discussion|0:0|The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_43|17662049|17494|#section_info|0:0|As shown in Fig. 2, while ICAM-1 cross-linking strongly enhanced cortactin tyrosine phosphorylation in RBE4 cells (Fig. 2a, lanes b and c), PECAM-1 cross-linking, which had no effect alone (Fig. 2a, lane d), markedly reduced ICAM-1-induced cortactin phosphorylation|#main_body|GO:0016310|phosphorylation|#go_definition|IDA|GOA|Icam1(25464)|#gene_synonym
0.75	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_112|17662049|20880|Results|0:0|Lanes a, d, g: basal condition; lanes b, e, h: ICAM-1 cross-linking; lanes c, f, i: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_44|17662049|17494|#section_info|0:0|As shown in Fig. 2, while ICAM-1 cross-linking strongly enhanced cortactin tyrosine phosphorylation in RBE4 cells (Fig. 2a, lanes b and c), PECAM-1 cross-linking, which had no effect alone (Fig. 2a, lane d), markedly reduced ICAM-1-induced cortactin phosphorylation|#main_body|GO:0050732|negative regulation of peptidyl-tyrosine phosphorylation|#go_definition|IDA|GOA|Pecam1(29583)|#gene_synonym
0.75	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_112|17662049|20880|Results|0:0|Lanes a, d, g: basal condition; lanes b, e, h: ICAM-1 cross-linking; lanes c, f, i: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_45|17662049|17494|#section_info|0:0|Partial inhibition of ICAM-1-induced cortactin phosphorylation was already observed after only 5 min of PECAM-1 cross-linking (not shown).|#main_body|GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.74	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_90|17662049|13033|Results|0:0|As control, cross-linking of ICAM-1 followed by incubation with buffer alone or with the isotype-matched anti-MHC-II antibody (Fig. 1e) or anti-transferrin antibody (not shown) or again with the same anti-ICAM-1 antibody (not shown) imilar results were observed using the human microvascular endothelial cell line HBMEC of peripheral origin (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_46|17662049|17494|#section_info|0:0|Partial inhibition of ICAM-1-induced cortactin phosphorylation was already observed after only 5 min of PECAM-1 cross-linking (not shown).|#main_body|GO:0050732|negative regulation of peptidyl-tyrosine phosphorylation|#go_definition|IDA|GOA|Pecam1(29583)|#gene_synonym
0.74	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_90|17662049|13033|Results|0:0|As control, cross-linking of ICAM-1 followed by incubation with buffer alone or with the isotype-matched anti-MHC-II antibody (Fig. 1e) or anti-transferrin antibody (not shown) or again with the same anti-ICAM-1 antibody (not shown) imilar results were observed using the human microvascular endothelial cell line HBMEC of peripheral origin (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_47|17662049|18251|#section_info|0:0|PECAM-1 cross-linking reverses ICAM-1-induced cortactin phosphorylation. Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells or HBMECs as described in Material and methods.|#fig_caption|GO:0001933|negative regulation of protein phosphorylation|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.83	17662049_107|17662049|20880|Results|0:0|Panel (a) Cross-linking of ICAM-1 or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.83	17662049_110|17662049|20880|Results|0:0|Panel (b) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated mock-transfected HBMECs or stably expressing WT-SHP-2 or Dn-SHP-2 as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.83	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_54|17662049|9298|Materials and methods|0:0|Experimental procedure for sequential cross-linking of ICAM-1 and/or PECAM-1 at the surface of cultured endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_45|17662049|7956|Materials and methods|0:0|Ab cross-linking of ICAM-1 and PECAM-1|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_46|17662049|7995|Materials and methods|0:0|Confluent endothelial cells were pre-incubated with serum- and growth factor-free culture medium containing 100 U/mL IFN-gamma for 48 h, before Ab cross-linking of ICAM-1 and/or PECAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_60|17662049|10094|Materials and methods|0:0|In order to inhibit SHP-2 phosphatase, endothelial cells (RBE-4 or HBMECs) were treated with 150 mug/mL of calpeptin (Calbiochem, La Jolla, CA, USA) for 30 min prior to ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_126|17662049|23562|Results|0:0|Panels (b-e) IFN-gamma-treated RBE4 cells were treated or not with calpeptin (150 mug/mL for 30 min) prior to ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_90|17662049|13033|Results|0:0|As control, cross-linking of ICAM-1 followed by incubation with buffer alone or with the isotype-matched anti-MHC-II antibody (Fig. 1e) or anti-transferrin antibody (not shown) or again with the same anti-ICAM-1 antibody (not shown) imilar results were observed using the human microvascular endothelial cell line HBMEC of peripheral origin (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_259|17662049|39611|Discussion|0:0|PECAM-1|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_48|17662049|18251|#section_info|0:0|PECAM-1 cross-linking reverses ICAM-1-induced cortactin phosphorylation. Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells or HBMECs as described in Material and methods.|#fig_caption|GO:0001934|positive regulation of protein phosphorylation|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.83	17662049_107|17662049|20880|Results|0:0|Panel (a) Cross-linking of ICAM-1 or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.83	17662049_110|17662049|20880|Results|0:0|Panel (b) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated mock-transfected HBMECs or stably expressing WT-SHP-2 or Dn-SHP-2 as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.83	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_54|17662049|9298|Materials and methods|0:0|Experimental procedure for sequential cross-linking of ICAM-1 and/or PECAM-1 at the surface of cultured endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_45|17662049|7956|Materials and methods|0:0|Ab cross-linking of ICAM-1 and PECAM-1|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_46|17662049|7995|Materials and methods|0:0|Confluent endothelial cells were pre-incubated with serum- and growth factor-free culture medium containing 100 U/mL IFN-gamma for 48 h, before Ab cross-linking of ICAM-1 and/or PECAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_60|17662049|10094|Materials and methods|0:0|In order to inhibit SHP-2 phosphatase, endothelial cells (RBE-4 or HBMECs) were treated with 150 mug/mL of calpeptin (Calbiochem, La Jolla, CA, USA) for 30 min prior to ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_96|17662049|17494|Results|0:0|As a control, cross-linking of the IFN-gamma -induced MHC class II proteins by an isotype-matched anti-MHC-II antibody (Fig. 2a, lane f) or of transferrin receptors (not shown) did not affect ICAM-1-induced cortactin phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_126|17662049|23562|Results|0:0|Panels (b-e) IFN-gamma-treated RBE4 cells were treated or not with calpeptin (150 mug/mL for 30 min) prior to ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_90|17662049|13033|Results|0:0|As control, cross-linking of ICAM-1 followed by incubation with buffer alone or with the isotype-matched anti-MHC-II antibody (Fig. 1e) or anti-transferrin antibody (not shown) or again with the same anti-ICAM-1 antibody (not shown) imilar results were observed using the human microvascular endothelial cell line HBMEC of peripheral origin (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_259|17662049|39611|Discussion|0:0|PECAM-1|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_49|17662049|18251|#section_info|0:0|Panel (c) PECAM-1 cross-linking prevents ICAM-1-induced cortactin phosphorylation in RBE4 cells. |#fig_caption|GO:0001933|negative regulation of protein phosphorylation|#go_definition|IDA|GOA|Pecam1(29583)|#gene_synonym
0.8	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_129|17662049|23562|Results|0:0|Panel (c) ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_131|17662049|23562|Results|0:0|Panel (e) ICAM-1 cross-linking after calpeptin treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_107|17662049|20880|Results|0:0|Panel (a) Cross-linking of ICAM-1 or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_50|17662049|18251|#section_info|0:0|Panel (c) PECAM-1 cross-linking prevents ICAM-1-induced cortactin phosphorylation in RBE4 cells. |#fig_caption|GO:0001934|positive regulation of protein phosphorylation|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.8	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_129|17662049|23562|Results|0:0|Panel (c) ICAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_131|17662049|23562|Results|0:0|Panel (e) ICAM-1 cross-linking after calpeptin treatment.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_107|17662049|20880|Results|0:0|Panel (a) Cross-linking of ICAM-1 or PECAM-1 was performed on IFN-gamma-treated RBE4 cells as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_51|17662049|19478|#section_info|0:0|Figure 2c reveals that inhibition of ICAM-1-induced cortactin phosphorylation was even more drastic in this case (Fig. 2c, lanes P + I) than when PECAM-1 cross-linking followed ICAM-1 cross-linking as above (Fig. 2c, lanes I + P).|#main_body|GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.65	17662049_112|17662049|20880|Results|0:0|Lanes a, d, g: basal condition; lanes b, e, h: ICAM-1 cross-linking; lanes c, f, i: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_52|17662049|19478|#section_info|0:0|Figure 2c reveals that inhibition of ICAM-1-induced cortactin phosphorylation was even more drastic in this case (Fig. 2c, lanes P + I) than when PECAM-1 cross-linking followed ICAM-1 cross-linking as above (Fig. 2c, lanes I + P).|#main_body|GO:0050732|negative regulation of peptidyl-tyrosine phosphorylation|#go_definition|IDA|GOA|Pecam1(29583)|#gene_synonym
0.65	17662049_112|17662049|20880|Results|0:0|Lanes a, d, g: basal condition; lanes b, e, h: ICAM-1 cross-linking; lanes c, f, i: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_125|17662049|23562|Results|0:0|Lanes a, d: basal condition; lanes b, e: ICAM-1 cross-linking; lanes c, f: sequential ICAM-1 and PECAM-1 cross-linking.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_89|17662049|13033|Results|0:0|By contrast, no stress fiber formation was observed following PECAM-1 cross-linking (Fig. 1c).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_101|17662049|18251|Results|0:0|Lane a: basal condition; lanes b and c: ICAM-1 cross-linking (b, 5 mug/mL and c, 10 mug/mL of ICAM-1 antibodies); lane d: PECAM-1 cross-linking (10 mug/mL); lane e: sequential ICAM-1 and then PECAM-1 (10 mug/mL each) cross-linking; lane f: sequential ICAM-1 and then MHC class II cross-linking (10 mug/mL each).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_53|17662049|19934|#section_info|0:0|Altogether, these findings support the conclusion that PECAM-1 engagement on the surface of brain (and non-brain) endothelial cells drastically inhibits multiple ICAM-1 signaling pathways, including cortactin phosphorylation and actin rearrangements.|#main_body|GO:0001932|regulation of protein phosphorylation|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.8	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_138|17662049|25760|Discussion|0:0|Moreover, these findings suggest that the tyrosine phosphatase SHP-2, as an upstream mediator of both PECAM-1 and ICAM-1 signaling pathways, might be a key player in the cross-talk identified here between these pathways.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_196|17662049|32057|Discussion|0:0|Formation of these docking structures results from the dynamic redistribution of several adhesion molecules including ICAM-1 and actin polymerization.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_6|17662049|93|abstract|0:0|We present evidence that the PECAM-1-associated tyrosine phosphatase SHP-2 is required for ICAM-1 signaling, suggesting that its activity might crucially contribute to the regulation of ICAM-1 signaling by PECAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_136|17662049|25222|Results|0:0|Together, we propose that SHP-2 might be a key player at the crossroads between ICAM-1 and PECAM-1 signalings in endothelial cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_198|17662049|32057|Discussion|0:0|Future studies will aim at evaluating the functional relevance of these findings, by evaluating the role of the PECAM-1 cytoplasmic domain and associated signaling in regulation of leukocyte transmigration across brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_171|17662049|29084|Discussion|0:0|This is to our knowledge the first evidence that PECAM-1 engagement can negatively regulate the signaling pathways coupled to another leukocyte adhesion molecule in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_172|17662049|29084|Discussion|0:0|This observation strongly suggests that leukocyte adhesion and transmigration trigger in endothelial cells a complex set of interconnected positive and negative signalings which cooperate for controlling the dynamics of endothelial response.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_217|17662049|35255|Discussion|0:0|ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_151|17662049|26237|Discussion|0:0|In addition, it has been suggested that SHP-2 might associate with tyrosine phosphorylated ICAM-1, even though ICAM-1 does not contain a bona fide SHP-2 binding site, such as a consensus immunoreceptor tyrosine-based inhibitory motif (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_184|17662049|31043|Discussion|0:0|Pharmacological inhibition of ICAM-1 coupled signalling pathways, using Rho kinase inhibitors or calcium chelators, largely prevented the migration of activated lymphocytes across RBE4 cells (Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_219|17662049|35515|Discussion|0:0|ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_236|17662049|37357|Discussion|0:0|Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck)|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_249|17662049|39056|Discussion|0:0|Activation of Src tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_1|17662049|0|paper_title|0:0|PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_54|17662049|19934|#section_info|0:0|Altogether, these findings support the conclusion that PECAM-1 engagement on the surface of brain (and non-brain) endothelial cells drastically inhibits multiple ICAM-1 signaling pathways, including cortactin phosphorylation and actin rearrangements.|#main_body|GO:0030837|negative regulation of actin filament polymerization|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.8	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_82|17662049|12697|Results|0:0|In order to assess the existence of a putative cross-talk between the signaling pathways coupled to ICAM-1 and PECAM-1 in brain endothelial cells, we developed a procedure of sequential antibody cross-linking of ICAM-1 and PECAM-1 (see Materials and methods) to mimic the supposed sequence of events supporting leukocyte extravasation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_251|17662049|39287|Discussion|0:0|Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_138|17662049|25760|Discussion|0:0|Moreover, these findings suggest that the tyrosine phosphatase SHP-2, as an upstream mediator of both PECAM-1 and ICAM-1 signaling pathways, might be a key player in the cross-talk identified here between these pathways.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_196|17662049|32057|Discussion|0:0|Formation of these docking structures results from the dynamic redistribution of several adhesion molecules including ICAM-1 and actin polymerization.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_6|17662049|93|abstract|0:0|We present evidence that the PECAM-1-associated tyrosine phosphatase SHP-2 is required for ICAM-1 signaling, suggesting that its activity might crucially contribute to the regulation of ICAM-1 signaling by PECAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_136|17662049|25222|Results|0:0|Together, we propose that SHP-2 might be a key player at the crossroads between ICAM-1 and PECAM-1 signalings in endothelial cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_198|17662049|32057|Discussion|0:0|Future studies will aim at evaluating the functional relevance of these findings, by evaluating the role of the PECAM-1 cytoplasmic domain and associated signaling in regulation of leukocyte transmigration across brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_143|17662049|26237|Discussion|0:0|We previously identified multiple signaling pathways activated in rat brain endothelial cell lines, following ICAM-1 cross-linking or leukocyte adhesion.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_171|17662049|29084|Discussion|0:0|This is to our knowledge the first evidence that PECAM-1 engagement can negatively regulate the signaling pathways coupled to another leukocyte adhesion molecule in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_172|17662049|29084|Discussion|0:0|This observation strongly suggests that leukocyte adhesion and transmigration trigger in endothelial cells a complex set of interconnected positive and negative signalings which cooperate for controlling the dynamics of endothelial response.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_217|17662049|35255|Discussion|0:0|ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_81|17662049|12617|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced actin cytoskeleton rearrangements|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_151|17662049|26237|Discussion|0:0|In addition, it has been suggested that SHP-2 might associate with tyrosine phosphorylated ICAM-1, even though ICAM-1 does not contain a bona fide SHP-2 binding site, such as a consensus immunoreceptor tyrosine-based inhibitory motif (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_184|17662049|31043|Discussion|0:0|Pharmacological inhibition of ICAM-1 coupled signalling pathways, using Rho kinase inhibitors or calcium chelators, largely prevented the migration of activated lymphocytes across RBE4 cells (Adamson et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_219|17662049|35515|Discussion|0:0|ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_236|17662049|37357|Discussion|0:0|Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck)|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_249|17662049|39056|Discussion|0:0|Activation of Src tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_1|17662049|0|paper_title|0:0|PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_47|17662049|7995|Materials and methods|0:0|This treatment has been shown to increase significantly the surface expression of ICAM-1 in RBE4 cells and was thus included in the ICAM-1 cross-linking procedure, as described (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_93|17662049|16822|Results|0:0|PECAM-1 cross-linking inhibits ICAM-1-induced cortactin phosphorylation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_123|17662049|23562|Results|0:0|Panel (a) Sequential cross-linking of ICAM-1 and/or PECAM-1 was performed on IFN-gamma-treated RBE4 cells pre-incubated with or without the selective SHP-2 inhibitor calpeptin (150 mug/mL) as described in Material and methods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_55|17662049|20290|#section_info|0:0|The tyrosine phosphatase SHP-2, is known to bind to activated PECAM-1.|#main_body|GO:0005515|protein binding|#go_definition|NAS|GOA|Ptpn11(25622)|#gene_synonym
0.68	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_104|17662049|20185|Results|0:0|The tyrosine phosphatase SHP-2 is at the crossroad between ICAM-1 and PECAM-1-coupled signaling pathways|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_106|17662049|20880|Results|0:0|SHP-2 is recruited by cross-linked ICAM-1 and PECAM-1.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_151|17662049|26237|Discussion|0:0|In addition, it has been suggested that SHP-2 might associate with tyrosine phosphorylated ICAM-1, even though ICAM-1 does not contain a bona fide SHP-2 binding site, such as a consensus immunoreceptor tyrosine-based inhibitory motif (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_226|17662049|36403|Discussion|0:0|Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_56|17662049|24636|#section_info|0:0|In conclusion, the main findings of the current study are summarized in Fig. 5: they demonstrate that SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements. |#main_body|GO:0018108|peptidyl-tyrosine phosphorylation|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.92	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.9	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_138|17662049|25760|Discussion|0:0|Moreover, these findings suggest that the tyrosine phosphatase SHP-2, as an upstream mediator of both PECAM-1 and ICAM-1 signaling pathways, might be a key player in the cross-talk identified here between these pathways.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_6|17662049|93|abstract|0:0|We present evidence that the PECAM-1-associated tyrosine phosphatase SHP-2 is required for ICAM-1 signaling, suggesting that its activity might crucially contribute to the regulation of ICAM-1 signaling by PECAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_151|17662049|26237|Discussion|0:0|In addition, it has been suggested that SHP-2 might associate with tyrosine phosphorylated ICAM-1, even though ICAM-1 does not contain a bona fide SHP-2 binding site, such as a consensus immunoreceptor tyrosine-based inhibitory motif (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_240|17662049|37890|Discussion|0:0|The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_104|17662049|20185|Results|0:0|The tyrosine phosphatase SHP-2 is at the crossroad between ICAM-1 and PECAM-1-coupled signaling pathways|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_178|17662049|31043|Discussion|0:0|We and others provided compelling evidence that ICAM-1-induced signaling and subsequent actin cytoskeleton remodeling was directly involved in the process of trans-endothelial migration of activated leukocytes (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_157|17662049|28313|Discussion|0:0|SHP-2 is known as an upstream mediator of multiple signaling pathways, but contrasting data in various cell systems present it either as a negative or a positive regulator of RhoA and other pathways (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_57|17662049|24636|#section_info|0:0|In conclusion, the main findings of the current study are summarized in Fig. 5: they demonstrate that SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements. |#main_body|GO:0018108|peptidyl-tyrosine phosphorylation|#go_definition|NONE|GOA|Ptpn11(25622)|#gene_synonym
0.92	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.9	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_138|17662049|25760|Discussion|0:0|Moreover, these findings suggest that the tyrosine phosphatase SHP-2, as an upstream mediator of both PECAM-1 and ICAM-1 signaling pathways, might be a key player in the cross-talk identified here between these pathways.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_6|17662049|93|abstract|0:0|We present evidence that the PECAM-1-associated tyrosine phosphatase SHP-2 is required for ICAM-1 signaling, suggesting that its activity might crucially contribute to the regulation of ICAM-1 signaling by PECAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_151|17662049|26237|Discussion|0:0|In addition, it has been suggested that SHP-2 might associate with tyrosine phosphorylated ICAM-1, even though ICAM-1 does not contain a bona fide SHP-2 binding site, such as a consensus immunoreceptor tyrosine-based inhibitory motif (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_240|17662049|37890|Discussion|0:0|The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_104|17662049|20185|Results|0:0|The tyrosine phosphatase SHP-2 is at the crossroad between ICAM-1 and PECAM-1-coupled signaling pathways|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_178|17662049|31043|Discussion|0:0|We and others provided compelling evidence that ICAM-1-induced signaling and subsequent actin cytoskeleton remodeling was directly involved in the process of trans-endothelial migration of activated leukocytes (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_157|17662049|28313|Discussion|0:0|SHP-2 is known as an upstream mediator of multiple signaling pathways, but contrasting data in various cell systems present it either as a negative or a positive regulator of RhoA and other pathways (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_58|17662049|24636|#section_info|0:0|In conclusion, the main findings of the current study are summarized in Fig. 5: they demonstrate that SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements. |#main_body|GO:0031532|actin cytoskeleton reorganization|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.92	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.9	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_138|17662049|25760|Discussion|0:0|Moreover, these findings suggest that the tyrosine phosphatase SHP-2, as an upstream mediator of both PECAM-1 and ICAM-1 signaling pathways, might be a key player in the cross-talk identified here between these pathways.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_6|17662049|93|abstract|0:0|We present evidence that the PECAM-1-associated tyrosine phosphatase SHP-2 is required for ICAM-1 signaling, suggesting that its activity might crucially contribute to the regulation of ICAM-1 signaling by PECAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_151|17662049|26237|Discussion|0:0|In addition, it has been suggested that SHP-2 might associate with tyrosine phosphorylated ICAM-1, even though ICAM-1 does not contain a bona fide SHP-2 binding site, such as a consensus immunoreceptor tyrosine-based inhibitory motif (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_240|17662049|37890|Discussion|0:0|The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_104|17662049|20185|Results|0:0|The tyrosine phosphatase SHP-2 is at the crossroad between ICAM-1 and PECAM-1-coupled signaling pathways|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_178|17662049|31043|Discussion|0:0|We and others provided compelling evidence that ICAM-1-induced signaling and subsequent actin cytoskeleton remodeling was directly involved in the process of trans-endothelial migration of activated leukocytes (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_157|17662049|28313|Discussion|0:0|SHP-2 is known as an upstream mediator of multiple signaling pathways, but contrasting data in various cell systems present it either as a negative or a positive regulator of RhoA and other pathways (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_59|17662049|24636|#section_info|0:0|In conclusion, the main findings of the current study are summarized in Fig. 5: they demonstrate that SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements. |#main_body|GO:0031532|actin cytoskeleton reorganization|#go_definition|NONE|GOA|Ptpn11(25622)|#gene_synonym
0.92	17662049_163|17662049|28313|Discussion|0:0|These results, summarized in Fig. 5, clearly establish that SHP-2 is positively involved in ICAM-1 signaling in endothelial cells, upstream of the Src-mediated tyrosine phosphorylation of cortactin as well as RhoA-mediated actin cytoskeleton rearrangements.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.9	17662049_134|17662049|25222|Results|0:0|SHP-2 is positively involved in ICAM-1 signaling, upstream of the tyrosine phosphorylation of cortactin by Src and of RhoA-mediated actin cytoskeleton rearrangements.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	17662049_4|17662049|93|abstract|0:0|Investigating signaling pathways triggered by the engagement of adhesion molecules expressed on brain endothelial cells, we previously documented the role of ICAM-1 in activation of the tyrosine phosphorylation of several actin-binding proteins and subsequent rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	17662049_116|17662049|21915|Results|0:0|Following antibody cross-linking of ICAM-1, we observed that expression of Dn-SHP-2 abolished the ICAM-1 induced tyrosine phosphorylation of cortactin (Fig. 3b, lane h), pointing to SHP-2 as a positive regulator of the Src-cortactin pathway in endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	17662049_137|17662049|25760|Discussion|0:0|We show in the present study that PECAM-1 engagement by antibody cross-linking totally blocked ICAM-1-induced activation of RhoA and subsequent changes in actin cytoskeleton, as well as tyrosine phosphorylation of cortactin in rat brain endothelial cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_138|17662049|25760|Discussion|0:0|Moreover, these findings suggest that the tyrosine phosphatase SHP-2, as an upstream mediator of both PECAM-1 and ICAM-1 signaling pathways, might be a key player in the cross-talk identified here between these pathways.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	17662049_144|17662049|26237|Discussion|0:0|In particular, we demonstrated activation of the tyrosine kinase Src and tyrosine phosphorylation of several cytoskeleton-associated proteins, including cortactin (Etienne et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	17662049_197|17662049|32057|Discussion|0:0|The current study strongly suggests that PECAM-1 engagement during paracellular extravasation of leukocytes, which has been well-documented to contribute to leukocyte diapedesis, may also regulate this process by limiting the ICAM-1 induced actin cytoskeleton rearrangements, downstream of the formation of docking structures.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_162|17662049|28313|Discussion|0:0|Here we showed that a dominant negative form of SHP-2 (Dn-SHP-2) or calpeptin inhibition of SHP-2 enzymatic activity largely inhibited the ICAM-1-mediated tyrosine phosphorylation of cortactin and actin stress fiber formation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_176|17662049|29084|Discussion|0:0|Alternatively, other proteins involved in the maintenance of endothelial junction integrity such as beta- or gamma-catenin, PLC-gamma, which are also known to interact with the cytosolic domain of PECAM-1, might be involved in the regulatory loop identified here between ICAM-1 and PECAM-1 (Ilan and Madri 2003).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	17662049_6|17662049|93|abstract|0:0|We present evidence that the PECAM-1-associated tyrosine phosphatase SHP-2 is required for ICAM-1 signaling, suggesting that its activity might crucially contribute to the regulation of ICAM-1 signaling by PECAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	17662049_154|17662049|26237|Discussion|0:0|In the present study, the moderate amount of SHP-2 bound to ICAM-1 (compared with SHP-2 bound to PECAM-1) following antibody cross-linking may be related to a very low level of ICAM-1 tyrosine phosphorylation (not detected here or in a previous studies (Greenwood et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_117|17662049|21915|Results|0:0|By contrast, over-expression of the wild type enzyme had no effect (Fig. 3b, lane e), suggesting that endogenous SHP-2 activity was sufficient for a maximal stimulation of cortactin phosphorylation by ICAM-1 cross-linking.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	17662049_151|17662049|26237|Discussion|0:0|In addition, it has been suggested that SHP-2 might associate with tyrosine phosphorylated ICAM-1, even though ICAM-1 does not contain a bona fide SHP-2 binding site, such as a consensus immunoreceptor tyrosine-based inhibitory motif (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_215|17662049|35008|Discussion|0:0|Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_164|17662049|29084|Discussion|0:0|PECAM-1 has been convincingly shown to transduce inhibitory signals in a variety of cell types, including endothelial cells, through SHP-2 binding to a tyrosine-phosphorylated immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain (Masuda et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_200|17662049|32057|Discussion|0:0|It can be hypothesized that caveolae or caveolin-rich microdomains may facilitate the functional interaction between ICAM-1- and PECAM-1 signalings in as much as PECAM-1 is present in these structures whereas ICAM-1 was recently shown to be recruited in similar structures following antibody cross-linking (Millan et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_240|17662049|37890|Discussion|0:0|The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_104|17662049|20185|Results|0:0|The tyrosine phosphatase SHP-2 is at the crossroad between ICAM-1 and PECAM-1-coupled signaling pathways|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_121|17662049|21915|Results|0:0|2003) drastically affected the formation of actin stress fibers in response to antibody cross-linking of ICAM-1 in RBE4 cells (Fig. 4e) and in HBMECs (not shown).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_148|17662049|26237|Discussion|0:0|In spite of the short C-terminal domain of ICAM-1, which comprises 27 amino acids in rat and 28 amino acids in human, biochemical studies have demonstrated that ICAM-1 is capable of binding a number of intracellular proteins in endothelial cells: the actin-binding protein alpha-actinin, the microtubule-associated beta-tubulin, the enzyme glyceraldehyde-3-phosphate dehydrogenase and ezrin, a linker between integral membrane proteins and the actin-cytoskeleton (Federici et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_178|17662049|31043|Discussion|0:0|We and others provided compelling evidence that ICAM-1-induced signaling and subsequent actin cytoskeleton remodeling was directly involved in the process of trans-endothelial migration of activated leukocytes (Durieu-Trautmann et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	17662049_157|17662049|28313|Discussion|0:0|SHP-2 is known as an upstream mediator of multiple signaling pathways, but contrasting data in various cell systems present it either as a negative or a positive regulator of RhoA and other pathways (Pluskota et al.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_60|17662049|24636|#section_info|0:0|More importantly, our results show that PECAM-1 engagement, which induces a strong interaction with SHP-2,|#main_body|GO:0005515|protein binding|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.78	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_61|17662049|24636|#section_info|0:0|More importantly, our results show that PECAM-1 engagement, which induces a strong interaction with SHP-2,|#main_body|GO:0005515|protein binding|#go_definition|NONE|GOA|Ptpn11(25622)|#gene_synonym
0.78	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	17662049_170|17662049|29084|Discussion|0:0|The results of the present study showed that PECAM-1 engagement concomitantly induced SHP-2 binding to PECAM-1 and blocked the SHP-2-dependent phosphorylation of cortactin and rearrangements of the actin cytoskeleton evoked by ICAM-1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	17662049_173|17662049|29084|Discussion|0:0|Although our study cannot firmly establish a direct role for SHP-2 in PECAM-1-coupled inhibition of ICAM-1 signaling, it is tempting to speculate that activated PECAM-1, by efficiently recruiting SHP-2, may sequester it away from ICAM-1 and inhibit RhoA and Src activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	17662049_5|17662049|93|abstract|0:0|In the present study, we show that, whereas PECAM-1 is known to control positively the trans-endothelial migration of leukocytes via homophilic interactions between leukocytes and endothelial cells, PECAM-1 engagement on brain endothelial surface unexpectedly counteracts the ICAM-1-induced tyrosine phosphorylation of cortactin and rearrangements of the actin cytoskeleton.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	17662049_113|17662049|21915|Results|0:0|Moreover, focusing on ICAM-1 signaling pathway, we observed a slight but consistent increase in the amount of SHP-2 in ICAM-1 immunoprecipitates following antibody cross-linking, although we failed to detect any ICAM-1 phosphorylation (Fig. 3a, lane d): this result suggested a non-conventional or indirect interaction between ICAM-1 and SHP-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_62|17662049|24636|#section_info|0:0|drastically inhibits these two distinct ICAM-1 activated pathways.|#main_body|GO:0050732|negative regulation of peptidyl-tyrosine phosphorylation|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.78	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_63|17662049|24636|#section_info|0:0|drastically inhibits these two distinct ICAM-1 activated pathways.|#main_body|GO:0030837|negative regulation of actin filament polymerization|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.78	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_64|17662049|24636|#section_info|0:0|drastically inhibits these two distinct ICAM-1 activated pathways.|#main_body|GO:0016310|phosphorylation|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.78	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_65|17662049|24636|#section_info|0:0|drastically inhibits these two distinct ICAM-1 activated pathways.|#main_body|GO:0030838|positive regulation of actin filament polymerization|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.78	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_66|17662049|24636|#section_info|0:0|drastically inhibits these two distinct ICAM-1 activated pathways.|#main_body|GO:0050732|negative regulation of peptidyl-tyrosine phosphorylation|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.78	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_68|17662049|24636|#section_info|0:0|drastically inhibits these two distinct ICAM-1 activated pathways.|#main_body|GO:0050731|positive regulation of peptidyl-tyrosine phosphorylation|#go_definition|NONE|GOA|Pecam1(29583)|#gene_synonym
0.78	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
17662049_69|17662049|24636|#section_info|0:0|drastically inhibits these two distinct ICAM-1 activated pathways.|#main_body|GO:0030838|positive regulation of actin filament polymerization|#go_definition|NONE|GOA|Icam1(25464)|#gene_synonym
0.78	17662049_135|17662049|25222|Results|0:0|In this study, we show that PECAM-1 engagement, which induces a strong interaction with SHP-2, drastically inhibits these two distinct ICAM-1 activated pathways.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
